D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 73 Citations 23,411 225 World Ranking 13315 National Ranking 69

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Cancer

His main research concerns Genome-wide association study, Primary sclerosing cholangitis, Immunology, Genetics and Inflammatory bowel disease. His study in Genome-wide association study is interdisciplinary in nature, drawing from both Disease, Genetic predisposition, Genetic association and Locus. His Primary sclerosing cholangitis study is related to the wider topic of Internal medicine.

His work on Human leukocyte antigen as part of general Immunology study is frequently linked to Alkaline phosphatase, therefore connecting diverse disciplines of science. His Genetics study incorporates themes from Inflammatory response and Primary biliary cirrhosis. As part of the same scientific family, Tom H. Karlsen usually focuses on Inflammatory bowel disease, concentrating on Allele and intersecting with Medical genetics, IRGM and Genetic architecture.

His most cited work include:

  • Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease (3117 citations)
  • Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. (1061 citations)
  • Genomewide Association Study of Severe Covid-19 with Respiratory Failure. (594 citations)

What are the main themes of his work throughout his whole career to date?

Tom H. Karlsen mainly investigates Primary sclerosing cholangitis, Internal medicine, Immunology, Gastroenterology and Genetics. His Primary sclerosing cholangitis research is multidisciplinary, incorporating perspectives in Liver transplantation, Inflammatory bowel disease and Ulcerative colitis. His Inflammatory bowel disease study combines topics in areas such as Crohn's disease and Pathogenesis.

His work on Liver disease, Hepatology, Framingham Risk Score and Cohort as part of his general Internal medicine study is frequently connected to In patient, thereby bridging the divide between different branches of science. His work in Immunology is not limited to one particular discipline; it also encompasses Allele. His Genome-wide association study study necessitates a more in-depth grasp of Single-nucleotide polymorphism.

He most often published in these fields:

  • Primary sclerosing cholangitis (73.07%)
  • Internal medicine (44.89%)
  • Immunology (34.98%)

What were the highlights of his more recent work (between 2018-2021)?

  • Primary sclerosing cholangitis (73.07%)
  • Internal medicine (44.89%)
  • Inflammatory bowel disease (25.08%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Primary sclerosing cholangitis, Internal medicine, Inflammatory bowel disease, Gastroenterology and Pathology. Tom H. Karlsen interconnects Liver transplantation, Immunology, Bile acid, Ulcerative colitis and Fibrosis in the investigation of issues within Primary sclerosing cholangitis. The various areas that he examines in his Inflammatory bowel disease study include Ursodeoxycholic acid, Cirrhosis, Cancer and Genetic association.

His work carried out in the field of Pathology brings together such families of science as Natural killer T cell and Bile duct. His Human leukocyte antigen research focuses on subjects like Linkage disequilibrium, which are linked to Disease. He works mostly in the field of Disease, limiting it down to concerns involving Genome-wide association study and, occasionally, Case-control study.

Between 2018 and 2021, his most popular works were:

  • Genomewide Association Study of Severe Covid-19 with Respiratory Failure. (594 citations)
  • EASL Clinical Practice Guidelines: Drug-induced liver injury (149 citations)
  • Obese Individuals with and without Type 2 Diabetes Show Different Gut Microbial Functional Capacity and Composition. (52 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Cancer

His scientific interests lie mostly in Primary sclerosing cholangitis, Internal medicine, Microbiome, Framingham Risk Score and Cohort. Primary sclerosing cholangitis is a subfield of Pathology that Tom H. Karlsen tackles. The Internal medicine study combines topics in areas such as Gastroenterology and Locus.

He has included themes like Inflammatory bowel disease, Zonulin, Pathophysiology, CD14 and Concomitant in his Gastroenterology study. Tom H. Karlsen has researched Cohort in several fields, including Biliary disease, Liver transplantation, Human leukocyte antigen and Hazard ratio. His research integrates issues of RNA, Area under the curve, Colitis and Cancer research in his study of Ulcerative colitis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

Luke Jostins;Stephan Ripke;Rinse K Weersma;Richard H Duerr.
Nature (2012)

3671 Citations

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.

Carl A. Anderson;Gabrielle Boucher;Charlie W. Lees;Andre Franke.
Nature Genetics (2011)

1359 Citations

Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility

Andre Franke;Tobias Balschun;Tom H Karlsen;Jurgita Sventoraityte.
Nature Genetics (2008)

639 Citations

Genomewide Association Study of Severe Covid-19 with Respiratory Failure.

David Ellinghaus;Frauke Degenhardt;Luis Bujanda;Maria Buti.
The New England Journal of Medicine (2020)

594 Citations

Primary sclerosing cholangitis

Gideon M Hirschfield;Tom H Karlsen;Tom H Karlsen;Keith D Lindor;David H Adams.
The Lancet (2013)

498 Citations

Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis.

Andre Franke;Tobias Balschun;Tom H Karlsen;Jürgen Hedderich.
Nature Genetics (2008)

439 Citations

Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci

David Ellinghaus;Luke Jostins;Sarah L. Spain;Adrian Cortes.
Nature Genetics (2016)

418 Citations

The First European Evidence-Based Consensus on Extra-Intestinal Manifestations in Inflammatory Bowel Disease

Marcus Harbord;Vito Annese;Stephan R Vavricka;Matthieu Allez.
Journal of Crohns & Colitis (2016)

402 Citations

Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota

Jun Wang;Louise B Thingholm;Jurgita Skiecevičienė;Philipp Rausch;Philipp Rausch.
Nature Genetics (2016)

370 Citations

Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2

Eva Ellinghaus;David Ellinghaus;Philip E Stuart;Rajan P Nair.
Nature Genetics (2010)

363 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Tom H. Karlsen

Andre Franke

Andre Franke

Kiel University

Publications: 157

Ramnik J. Xavier

Ramnik J. Xavier

Broad Institute

Publications: 142

Dermot P.B. McGovern

Dermot P.B. McGovern

Cedars-Sinai Medical Center

Publications: 95

Mark J. Daly

Mark J. Daly

University of Helsinki

Publications: 86

Stefan Schreiber

Stefan Schreiber

Kiel University

Publications: 83

Gideon M. Hirschfield

Gideon M. Hirschfield

University Health Network

Publications: 80

Ole A. Andreassen

Ole A. Andreassen

Oslo University Hospital

Publications: 78

Cisca Wijmenga

Cisca Wijmenga

University Medical Center Groningen

Publications: 76

Severine Vermeire

Severine Vermeire

KU Leuven

Publications: 72

Hakon Hakonarson

Hakon Hakonarson

Children's Hospital of Philadelphia

Publications: 72

Mark S. Silverberg

Mark S. Silverberg

University of Toronto

Publications: 69

Judy H. Cho

Judy H. Cho

Icahn School of Medicine at Mount Sinai

Publications: 63

Jack Satsangi

Jack Satsangi

John Radcliffe Hospital

Publications: 59

Keith D. Lindor

Keith D. Lindor

Arizona State University

Publications: 59

James T. Elder

James T. Elder

University of Michigan–Ann Arbor

Publications: 58

Scott B. Snapper

Scott B. Snapper

Boston Children's Hospital

Publications: 55

Trending Scientists

Barry Smyth

Barry Smyth

University College Dublin

Gang Pan

Gang Pan

Zhejiang University

Cheng Deng

Cheng Deng

Xidian University

Robert E. Litan

Robert E. Litan

Brookings Institution

Greg Christie

Greg Christie

Apple (United States)

Rubens Maciel Filho

Rubens Maciel Filho

State University of Campinas

Gonçalo J. L. Bernardes

Gonçalo J. L. Bernardes

University of Cambridge

Stephen G. Weller

Stephen G. Weller

University of California, Irvine

Dan Goldowitz

Dan Goldowitz

University of British Columbia

Zachary M. Easton

Zachary M. Easton

Virginia Tech

J. Mark FitzGerald

J. Mark FitzGerald

University of British Columbia

Gregor Verhoef

Gregor Verhoef

KU Leuven

John L. Humm

John L. Humm

Memorial Sloan Kettering Cancer Center

Marcia I. Canto

Marcia I. Canto

Johns Hopkins University

Julie Ratcliffe

Julie Ratcliffe

Flinders University

Isobel R. Contento

Isobel R. Contento

Columbia University

Something went wrong. Please try again later.